Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes

Hong Wang,Jie Cao,Jian-bin Su,Xue-qin Wang,Xing Wang,Dong-mei Zhang,Xiao-hua Wang

DOI: https://doi.org/10.1186/s13098-021-00690-z

2021-01-01

Diabetology & Metabolic Syndrome

Abstract:Background Serum fatty acid-binding protein 4 (FABP4), as an intracellular lipid chaperone and adipokine, was reported to be related to the incidence of type 2 diabetes (T2D) and diabetic complications, but its association with pancreatic islet β-cell and α-cell functions has not been fully elucidated. So the present study was to investigate the serum FABP4 levels and responses of islet β-cells and α-cells in patients with T2D. Methods 115 patients with T2D and 89 healthy controls (HC), who received serum FABP4 levels test, were recruited to participate in this study. Moreover, 75-g oral glucose tolerance test (OGTT) was performed in T2D patients to evaluate islet β-cell and α-cell functions. Systemic insulin sensitivity and overall insulin secretion of islet β-cell function were assessed by Matsuda index using C peptide (ISI M-cp ) and ratio of the area under the C peptide curve to the glucose curve (AUC cp/glu ) during OGTT, respectively. Fasting glucagon (Gluca 0min ) and postchallenge glucagon assessed by the area under the glucagon curve (AUC gluca ) were determined during OGTT to evaluate islet α-cell function. And other various clinical variables were also measured in all participants. Skewed variables were natural log-transformed (ln), such as lnFABP4. Results The serum FABP4 levels in T2D patients were significantly higher than those in HC ( p < 0.05). And after partially adjusting for fasting plasma glucose, serum lnFABP4 levels were negatively correlated with lnISI M-cp ( r = − 0.332, p < 0.001) and positively correlated with lnAUC cp/glu ( r = 0.324, p < 0.001), lnGluca 0min ( r = 0.200, p = 0.040) and lnAUC gluca ( r = 0.311, p < 0.001), respectively, in patients with T2D. Furthermore, when multiple linear regression analyses were applied to adjust for other various clinical variables, serum lnFABP4 levels were found to remain associated with lnISI M-cp ( β = − 0.296, t = − 2.900, p = 0.005), lnAUC cp/glu ( β = 0.223, t = 2.038, p = 0.046), lnGluca 0min ( β = 0.272, t = 2.330, p = 0.024) and lnAUC gluca ( β = 0.341, t = 3.065, p = 0.004), respectively. Conclusion Increased serum FABP4 levels were closely associated with blunted insulin sensitivity, increased insulin secretion, and elevated fasting and postchallenge glucagon levels in patients with T2D.